Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134173

Published: 2020

Journal Articles

Altered Structure and Function of Mesenchymal Stromal Cell-Derived Extracellular Matrix in MDS Can be Restored By Luspatercept

Manja Wobus, PhD, Anna Mies, Valentina Magno, PhD, Cindy Welzel, Susann Winter, PhD, Friedrich Stoelzel, MD, Carsten Werner, PhD, Martin Bornhaeuser, MD, Uwe Platzbecker, MD

Blood (2019) 134 (Supplement_1): 1699.

https://doi.org/10.1182/blood-2019-129814

Published: 2019

Journal Articles

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

Blood (2019) 134 (Supplement_1): 4563.

https://doi.org/10.1182/blood-2019-125087

Published: 2019

Journal Articles

A Novel Revcar Platform for Switchable and Gated Tumor Targeting

Anja Feldmann, PhD, Anja Hoffmann, Enrico Kittel-Boselli, Ralf Bergmann, PhD, Stefanie Koristka, PhD, Nicole Berndt, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Nicola Mitwasi, Justyna Jureczek, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5611.

https://doi.org/10.1182/blood-2019-128436

Published: 2019

Journal Articles

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Anja Feldmann, PhD, Stefanie Koristka, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Anja Hoffmann, Justyna Jureczek, Nicola Mitwasi, Martin Bornhaeuser, MD, Václav Hořejší, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5612.

https://doi.org/10.1182/blood-2019-128193

Published: 2019

Journal Articles

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Liliana Raquel Loureiro, PhD, Anja Feldmann, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Stefanie Koristka, PhD, Nicola Mitwasi, Anja Hoffmann, Justyna Jureczek, Martin Bornhaeuser, MD, Michael Bachmann, MD, Claudia Arndt, PhD

Blood (2019) 134 (Supplement_1): 5613.

https://doi.org/10.1182/blood-2019-128249

Published: 2019

Journal Articles

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Frederick Fasslrinner, MD, Claudia Arndt, PhD, Anja Feldmann, PhD, Stefanie Koristka, PhD, Liliana Raquel Loureiro, PhD, Marc Schmitz, MD, Gundram Jung, MD, Martin Bornhaeuser, MD, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5614.

https://doi.org/10.1182/blood-2019-124279

Published: 2019

Journal Articles

Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34 -/Lo MLL-Rearranged Leukemia

Tsz Kan Fung, Bernd Zeisig, Magdalena Zarowiecki, Huacheng Luo, Chiou Tsun Tsai, Boban Stanojevic, Claire Lynn, Anskar Y.-H. Leung, MD PhD, Jan Zuna, Marketa Zaliova, MD PhD, Martin Bornhaeuser, MD, Malte Von Bonin, Boris Lenhard, Suming Huang, PhD, Ghulam J. Mufti, Chi Wai Eric So

Blood (2019) 134 (Supplement_1): 3203.

https://doi.org/10.1182/blood-2019-125078

Published: 2019

Journal Articles

Prognostic Value of Cpss Cytogenetic Risk Classification in Patients with CMML after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study of the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 2182.

https://doi.org/10.1182/blood-2018-99-115981

Published: 2018

Journal Articles

Differences Between CEBPA bZIP and TAD Mutations and Their Effect on Outcome-an Analysis in 4578 Patients with Acute Myeloid Leukemia

Blood (2016) 128 (22): 283.

https://doi.org/10.1182/blood.V128.22.283.283

Published: 2016

Journal Articles

High Prevalence of Functional Laa Specific Cytotoxic T Lymphocytes in Healthy Individuals-Implications for Strategies in Adoptive T Cell Therapies of Relapsed Leukemia

Sarah Matko, Marcus Odendahl, PhD, Martin Bornhaeuser, MD, Torsten Tonn, MD PhD

Blood (2015) 126 (23): 5428.

https://doi.org/10.1182/blood.V126.23.5428.5428

Published: 2015

Journal Articles

Functional Influence of CXCL12 Regulating miRNAs in Mesenchymal Stem Cells (MSCs).

Laleh S. Arabanian, Fernando Fierro, David M. Poitz, PhD, Ruth H. Strasser, MD, Martin Bornhaeuser, MD, Gerhard Ehninger, Friedrich Stölzel, MD, Thomas Illmer

Blood (2012) 120 (21): 2350.

https://doi.org/10.1182/blood.V120.21.2350.2350

Published: 2012

Journal Articles

The Immunologic Composition of the Bone Marrow Changes Rapidly During the Harvest Procedure

Martin Wermke, MD, Cathrin Wegner, Malte von Bonin, MD, Sebastian Tuve, MD, Claudia Schönefeldt, MSc, Kristina Hölig, MD, Uta Oelschlegel, PhD, Martin Bornhaeuser, MD, Uwe Platzbecker, MD, Rainer Ordemann, MD

Blood (2012) 120 (21): 1915.

https://doi.org/10.1182/blood.V120.21.1915.1915

Published: 2012

Journal Articles

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

Friedrich Stölzel, MD, Christoph Röllig, Michael Kramer, Brigitte Mohr, Uta Oelschlägel, Jörgen Radke, Christian Thiede, Martin Bornhaeuser, MD, Gerhard Ehninger, MD, Markus Schaich, MD

Blood (2010) 116 (21): 2154.

https://doi.org/10.1182/blood.V116.21.2154.2154

Published: 2010

Journal Articles

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Friedrich Stölzel, MD, Klaus Zoephel, Christoph Röllig, Jörgen Radke, Johannes Schetelig, Uwe Platzbecker, Martin Bornhaeuser, MD, Gerhard Ehninger, MD, Jörg Kotzerke, Markus Schaich, MD

Blood (2010) 116 (21): 2156.

https://doi.org/10.1182/blood.V116.21.2156.2156

Published: 2010

Journal Articles

Reciprocal Regulation of DSCR1 (Down Syndrome Critical Region 1) Expression and NFAT (Nuclear Factor of Activated T Cells) Activation in Megakaryocytes.

Satu Kyttaelae, Ivonne Habermann, Martin Bornhaeuser, MD, Gerhard Ehninger, MD, Alexander Kiani, MD

Blood (2007) 110 (11): 2204.

https://doi.org/10.1182/blood.V110.11.2204.2204

Published: 2007

Journal Articles

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning in Patients with Relapsed or Refractory Acute Myeloid Leukemia - Results of a Phase I/II Trial.

Martin Bornhaeuser, MD, Thomas Illmer, MD, Platzbecker Uwe, MD, Ordemann Rainer, MD, Schetelig Johannes, MD, Schaich Markus, MD, Kiani Alexander, MD, Schuler Ulrich, MD, Ehninger Gerhard, MD

Blood (2007) 110 (11): 1997.

https://doi.org/10.1182/blood.V110.11.1997.1997

Published: 2007

Journal Articles

Role of Jagged/Notch Signaling in the Cell Fate Determination of Bone Marrow Human Mesenchymal Stem Cells.

Fernando Ugarte, Martin F. Ryser, MD, Sebastian Thieme, PhD, Martin Bornhaeuser, MD, PhD, Sebastian Brenner, MD

Blood (2007) 110 (11): 1923.

https://doi.org/10.1182/blood.V110.11.1923.1923

Published: 2007

Journal Articles

Interplay of CXCR4 and FLT3-ITD in the Regulation of Stem Cell Migration and Proliferation.

Angela Jacobi, Martin F. Ryser, MD, Sina Koch, Romy Lehmann, Martin Bornhaeuser, MD, PhD, Sebastian Brenner, MD

Blood (2007) 110 (11): 1818.

https://doi.org/10.1182/blood.V110.11.1818.1818

Published: 2007

Journal Articles

Treatment of Relapse of AML and MDS after Allogeneic Stem Cell Transplantation Using Low-Dose Chemotherapy, Donor PBSC and GM-CSF: Final Results from a Prospective, Multicenter Phase II Trial by the German Cooperative Transplant Group.

Christoph Schmid, MD, Johanna Tischer, MD, Matthias Stelljes, MD, Michael Schleuning, MD, Rainer Schwerdtfeger, MD, Ute Hegenbart, MD, Joerg Schubert, MD, Wichard Vogel, MD, Berd Gruhn, MD, Christiane Lallinger, Georg Ledderose, MD, Martin Bornhaeuser, MD, Joachim Kienast, MD, Hans-Jochem Kolb, MD

Blood (2007) 110 (11): 1651.

https://doi.org/10.1182/blood.V110.11.1651.1651

Published: 2007

NARROW

Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in Europe between 1995-2018: An EBMT Retrospective Analysis

Altered Structure and Function of Mesenchymal Stromal Cell-Derived Extracellular Matrix in MDS Can be Restored By Luspatercept

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

A Novel Revcar Platform for Switchable and Gated Tumor Targeting

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Development of Target Modules for Early and Late Stage Cancer Treatment Using Switchable Unicar T Cell Therapy

Targeting the FMS-like Tyrosin Kinase 3 with the Unicar System: Preclinical Comparison of Murine and Humanized Single-Chain Variable Fragment-Based Targeting Modules

Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34 -/Lo MLL-Rearranged Leukemia

Prognostic Value of Cpss Cytogenetic Risk Classification in Patients with CMML after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Multicenter Study of the Chronic Malignancies Working Party of the EBMT

Differences Between CEBPA bZIP and TAD Mutations and Their Effect on Outcome-an Analysis in 4578 Patients with Acute Myeloid Leukemia

High Prevalence of Functional Laa Specific Cytotoxic T Lymphocytes in Healthy Individuals-Implications for Strategies in Adoptive T Cell Therapies of Relapsed Leukemia

Functional Influence of CXCL12 Regulating miRNAs in Mesenchymal Stem Cells (MSCs).

The Immunologic Composition of the Bone Marrow Changes Rapidly During the Harvest Procedure

Characterization of Extramedullary Acute Myeloid Leukemia – Results of the AML96 Trial

PET-CT Scan for Detection of Extramedullary Acute Myeloid Leukemia

Reciprocal Regulation of DSCR1 (Down Syndrome Critical Region 1) Expression and NFAT (Nuclear Factor of Activated T Cells) Activation in Megakaryocytes.

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning in Patients with Relapsed or Refractory Acute Myeloid Leukemia - Results of a Phase I/II Trial.

Role of Jagged/Notch Signaling in the Cell Fate Determination of Bone Marrow Human Mesenchymal Stem Cells.

Interplay of CXCR4 and FLT3-ITD in the Regulation of Stem Cell Migration and Proliferation.

Treatment of Relapse of AML and MDS after Allogeneic Stem Cell Transplantation Using Low-Dose Chemotherapy, Donor PBSC and GM-CSF: Final Results from a Prospective, Multicenter Phase II Trial by the German Cooperative Transplant Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only